StepStone VC is excited to partner with AcuityMD after having participated in their recent Series B round which will be used to expand the Company's commercial intelligence platform. We look forward to supporting their mission of accelerating the adoption of cutting-edge medical technology. Full press release here: https://bit.ly/3VeQmLL #StepStoneVC #VentureCapital #medtech
StepStone Group’s Post
More Relevant Posts
-
Providing the best Talent and Services for your team globally within the Life Science / Biotech sector
🚀 Big News in MedTech! 🚀 AcuityMD has secured $45M in Series B funding to expand its innovative commercial intelligence platform for medical technology manufacturers! 🌟💡 This round was led by ICONIQ Growth, with participation from Atreides Management, LP, StepStone Group, and existing investors Redpoint Ventures Inc, Benchmark Capital, and Artisanal Ventures. To date, AcuityMD has raised over $83M, achieving a remarkable 10x increase in annual recurring revenue since its 2022 Series A raise. 📈💰 Key Highlights: 🔹 AcuityMD's platform transforms healthcare data into actionable insights, driving more than 25% sales growth for top reps and creating over $10B in opportunity pipeline. 🔹 Supporting over 200 MedTech manufacturers, including six of the top 10 globally. 🔹 Plans to launch three new products, expand the pipeline management solution, and grow the engineering and product teams by 70% by the end of 2024. 🚀🔬 "AcuityMD is a market leader in commercial MedTech software with powerful data and prospecting insights that have elicited positive feedback from customers," said Tengbo Li, Partner at ICONIQ Growth. With the backing of experienced MedTech executives and financial partners, AcuityMD is set to accelerate the adoption of cutting-edge medical technology, bringing new treatments to patients faster. 🏥💉 #MedTech #Funding #HealthcareInnovation #CommercialIntelligence #AcuityMD #ICONIQGrowth #TechInnovation #StartupSuccess 🚀🔬💰
To view or add a comment, sign in
-
🤔 What are the 4 Cs? 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻: How do I generate revenue in the healthcare industry? 𝗖𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻: How do I get my product and company certified? 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗦𝘁𝘂𝗱𝗶𝗲𝘀: How can I provide evidence by collecting clinical data? 𝗖𝗼𝗽𝘆𝗿𝗶𝗴𝗵𝘁: How can I use data/property rights to my advantage? ➡ The Medical Innovations Incubator GmbH is accepting applications for its #4CAccelerator for #medtech start-ups! ➡ If you are a founder with an innovative product idea in #medicaldevices or #invitro #diagnostics, check out this opportunity. 📆 Applications are due by 𝟭𝟵 𝗝𝗮𝗻𝘂𝗮𝗿𝘆❗ ➡ https://lnkd.in/eiENYKDS
To view or add a comment, sign in
-
-
Expert knowledge in Live, Hybrid and Virtual Event Organisation, for Congresses & Tradeshows, Corporate & Branding Events, Corporate Culture Program, Classical Concerts
🦾 We are transforming health tech. 🧠 We are The Brainlab Companies. 👪 And together, we are growing as one entity with one unified goal: advancing healthcare technology. I am proud to share some news on an exciting merge of exceptional talent and knowledge. “The Brainlab Companies are transforming the next era in patient care with the concerted and united goal to develop a data-driven ecosystem of the highest quality for providers and patients worldwide,” said Stefan Vilsmeier, President and CEO, Brainlab. In recent years, Brainlab has strategically acquired existing companies – Mint Medical, Langer Medical, Level Ex and Medphoton (majority acquisition) – and created the spin-off, Snke OS, establishing a diverse portfolio. Learn more about this strategic brand initiative here: https://lnkd.in/dCwHYUfV #WeAreBrainlab #brandstrategy #digitalhealth
Press Release: The Brainlab Companies
To view or add a comment, sign in
-
Advancing AI Solutions in Healthcare | Health Tech Strategist | Ex-Unicorn Startup | CTO/CIO | Startup advisor | Speaker | Mentor
#digital #health #funding AI-supported virtual MSK clinic Sword Health banks $130M AcuityMD, a software solution for medical device sales, rakes in $45M Eko Health nabs $41M for its digitally-enabled stethoscopes for cardiac care Anterior (formerly Co:Helm) nabs $20M to use AI to streamline administration tasks for payers and providers Life sciences-focused data validation and automation solution Sware closes on $6M Keragon, an AI-powered low-code integration and automation solution, emerges with $3M #venturecapital #digitalhealth #startups
To view or add a comment, sign in
-
#BusinessStrategy #HealthcareDiagnosis #CaseStudy - 38 In the dynamic world of healthcare technology, we've witnessed a significant milestone that signals a new era in medical diagnostics and patient care. Prenosis has achieved a groundbreaking success in sepsis detection, marking a pivotal moment that redefines both patient treatment protocols and the broader market landscape. Prenosis' recent FDA clearance for its ImmunoScore tool represents the first-ever approval of an AI diagnostic tool for sepsis. This achievement is not just a testament to the tool's innovative capabilities but also to the shift towards a more data-driven and personalized healthcare paradigm. At a time when sepsis remains a formidable global health challenge, the ability of an AI-powered tool to assess sepsis risk within a mere 24 hours is nothing short of revolutionary, promising to save lives and streamline healthcare processes. What sets Prenosis apart is not solely its technological innovation but also its strategic foresight in navigating the competitive healthcare landscape. By obtaining FDA clearance via the De Novo pathway, Prenosis has not only strengthened its market presence but has also established a new benchmark for regulatory trust and innovation in healthcare. This recognition from a regulatory authority as stringent as the FDA significantly boosts Prenosis' technology's credibility, making it more attractive to healthcare providers and investors alike. The market and industry's response to Prenosis' ImmunoScore has been exceptionally positive, signaling a shift towards greater acceptance and valuation of AI's role in transforming healthcare. This movement is indicative of a wider industry trend that values technologies capable of delivering more precise, timely, and individualized care solutions. For healthcare startups and entrepreneurs, Prenosis' journey illuminates several strategic paths: 🏥 Navigating Regulatory Approvals: Attaining regulatory nod can significantly distinguish your offering in the market and serve as a strong foundation of trust. 🏥 Harnessing Data for Precision: The integration of AI and machine learning into healthcare solutions underscores the shift towards precision medicine, offering tailored and precise care. 🏥 Forging Strategic Alliances: Building relationships with regulatory bodies and healthcare institutions can greatly enhance the adoption and integration of new technologies. 🏥 Prioritizing Trust and Transparency: Developing technologies with a keen focus on patient safety and data protection is crucial in building and maintaining market trust. So how you're planning to integrate these strategic insights into your ventures? Innovate Today, Inspire Tomorrow 💡 - Montaigne Smart Business Solutions #NavigatingHealthcareInnovation #StrategicAdvancement #HealthTechBreakthroughs #PioneeringPatientCare
To view or add a comment, sign in
-
-
Thrilled to have launched the first #VSPVisionInnovationChallenge with our friends at MATTER. While at #Inno, I saw over-and-over again the value of these programs, as both a catalyst for heightened visibility and a springboard to meaningful milestones (investment, partnership, big hire, etc.). I'm excited to be bringing this accelerant to vision care. Here's who we're looking for: Early-stage to mature solutions enhancing the eye care patient experience. That can mean you're... 💪 EMPOWERING PATIENTS by enabling them to proactively manage their eye health? 🚑 SCALING ACCESS and connecting patients and providers more efficiently and effectively to novel eye care solutions and experiences 🏥 ELEVATING CARE and aiding optometrists in providing an superior patient experience? Examples include... 🤖🤖Find-a-provider app, symptom checkers, digital therapeutics, portable devices, smart eyewear, care navigation, Dr. co-pilots, ambient medical scribes, AI-enabled disease detection, and more!🤖🤖 Is this you? Do you know an entrepreneur/startup that fits the bill? Check out our Challenge page to learn more and apply. https://lnkd.in/e-DTt8PE And please spread the word!
To view or add a comment, sign in
-
🦾 We are transforming health tech. 🧠 We are The Brainlab Companies. 👪 And together, we are growing as one entity with one unified goal: advancing healthcare technology. I am proud to share some news on an exciting merge of exceptional talent and knowledge. “The Brainlab Companies are transforming the next era in patient care with the concerted and united goal to develop a data-driven ecosystem of the highest quality for providers and patients worldwide,” said Stefan Vilsmeier, President and CEO, Brainlab. In recent years, Brainlab has strategically acquired existing companies – Mint Medical, Langer Medical, Level Ex and Medphoton (majority acquisition) – and created the spin-off, Snke OS, establishing a diverse portfolio. Learn more about this strategic brand initiative here: https://lnkd.in/gkTqNzdG #WeAreBrainlab #brandstrategy #digitalhealth
Press Release: The Brainlab Companies
To view or add a comment, sign in
-
“Inventing products — lots of people can do that. Innovating means actually getting it out into the world and making an impact, and it requires so much more than just a good problem statement and engineering. To really innovate, particularly in this healthcare system, you have to understand what it takes to get people access to the care and actually scale it.” Meet Kirsten Carroll, a strong leader with a quarter-century of expertise in #medicaldevices for neurovascular disorders. With a unique blend of academic and professional experience, including roles at Boston Scientific, Stryker, and Imperative Care, Kirsten is now leading the latter's spinout -Kandu Health™ which aims to significantly increase the quality of life of stroke survivors and their care partners. The impact? A startling 85% of the first 40 participants in Kandu's initial program were living independently by day 90. Amazing! 🔥 Here are some key insights from Kristen’s Medsider interview with Scott Nelson: ➡ To optimize for a fulfilling career in medtech, you need to continuously develop your skill sets. Take a layered approach to your decision-making, build a robust foundation of knowledge, and then trust your gut. 💗 ➡ Make sure the voices of your end users are heard. Kirsten's advisory board included stroke survivors who helped design and validate the product, every step of the way. 🙆🏾♀️ ➡ When taking on significant initiatives, adopt a process-oriented approach, break down big challenges into manageable, winnable steps, and build a team around you that is fully aligned with the mission. 📑 Check out the full interview where Kirsten shares her fresh approach to tackling the complexities of post-stroke care: (link in comments) This Medsider episode was brought to you by FastWave Medical, a hot IVL startup in the cardiovascular space. They closed their last capital raise in just a few weeks, so don’t miss out on the next one! See more details in the comments below. PS - We just launched exciting new features exclusively for Medsider premium members: ⭐ Playbooks: Go from 0 to 100 with hand-picked collections of the best Medsider interviews with the brightest founders and CEOs. ⭐ Investor database: Find your next medical device or health technology investor with our growing database of VC funds, equity investors, and high-net-worth angels. You can find links to both in the comments below.
Kirsten Carroll is redefining post-stroke care through her startup, Kandu Health, which offers services to improve life for stroke survivors.
To view or add a comment, sign in
-
🦾 We are transforming health tech. 🧠 We are The Brainlab Companies. 👪 And together, we are growing as one entity with one unified goal: advancing healthcare technology. I am proud to share some news on an exciting merge of exceptional talent and knowledge. “The Brainlab Companies are transforming the next era in patient care with the concerted and united goal to develop a data-driven ecosystem of the highest quality for providers and patients worldwide,” said Stefan Vilsmeier, President and CEO, Brainlab. In recent years, Brainlab has strategically acquired existing companies – Mint Medical, Langer Medical, Level Ex and Medphoton (majority acquisition) – and created the spin-off, Snke OS, establishing a diverse portfolio. Learn more about this strategic brand initiative here: https://lnkd.in/eUyzR3V3 #WeAreBrainlab #brandstrategy #digitalhealth
Press Release: The Brainlab Companies
To view or add a comment, sign in
-
🦾 We are transforming health tech. 🧠 We are The Brainlab Companies. 👪 And together, we are growing as one entity with one unified goal: advancing healthcare technology. “The Brainlab Companies are transforming the next era in patient care with the concerted and united goal to develop a data-driven ecosystem of the highest quality for providers and patients worldwide,” said Stefan Vilsmeier, President and CEO, Brainlab. In recent years, Brainlab has strategically acquired existing companies – Mint Medical, a Brainlab company, Langer Medical, a Brainlab company, Level Ex and Medphoton, a Brainlab company (majority acquisition) – and created the spin-off, Snke OS, a Brainlab company, establishing a diverse portfolio. This integration of expertise and capabilities has positioned The Brainlab Companies as a powerful force operating under one shared commitment: advancing healthcare technology. Learn more about our strategic brand initiative unifying all its subsidiaries under a new umbrella in this press release: https://lnkd.in/dYakiAhc #WeAreBrainlab #brandstrategy #digitalhealth
To view or add a comment, sign in